Preservation of acyl coenzyme A attenuates pathological and metabolic cardiac remodeling through selective lipid trafficking

JR Goldenberg, AN Carley, R Ji, X Zhang, M Fasano… - Circulation, 2019 - Am Heart Assoc
Background: Metabolic remodeling in heart failure contributes to dysfunctional lipid
trafficking and lipotoxicity. Acyl coenzyme A synthetase-1 (ACSL1) facilitates long-chain fatty …

Acyl CoA synthetase-1 links facilitated long chain fatty acid uptake to intracellular metabolic trafficking differently in hearts of male versus female mice

JR Goldenberg, X Wang, ED Lewandowski - Journal of molecular and …, 2016 - Elsevier
Abstract Rationale Acyl CoA synthetase-1 (ACSL1) is localized at intracellular membranes,
notably the mitochondrial membrane. ACSL1 and female sex are suggested to indirectly …

Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs fatty acid oxidation and induces cardiac hypertrophy

JM Ellis, SM Mentock, MA DePetrillo… - … and cellular biology, 2011 - Taylor & Francis
Long-chain acyl coenzyme A (acyl-CoA) synthetase isoform 1 (ACSL1) catalyzes the
synthesis of acyl-CoA from long-chain fatty acids and contributes the majority of cardiac long …

Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin

JC Schisler, TJ Grevengoed, F Pascual… - Journal of the …, 2015 - Am Heart Assoc
Background Long chain acyl‐CoA synthetases (ACSL) catalyze long‐chain fatty acids (FA)
conversion to acyl‐CoAs. Temporal ACSL 1 inactivation in mouse hearts (Acsl1 H−/−) …

[HTML][HTML] Acyl-CoA synthetase 1 deficiency alters cardiolipin species and impairs mitochondrial function

TJ Grevengoed, SA Martin, L Katunga, DE Cooper… - Journal of lipid …, 2015 - ASBMB
Long-chain acyl-CoA synthetase 1 (ACSL1) contributes more than 90% of total cardiac
ACSL activity, but its role in phospholipid synthesis has not been determined. Mice with an …

[HTML][HTML] Loss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 …

TJ Grevengoed, DE Cooper, PA Young… - The FASEB …, 2015 - ncbi.nlm.nih.gov
Because hearts with a temporally induced knockout of acyl-CoA synthetase 1 (Acsl1 T−/−)
are virtually unable to oxidize fatty acids, glucose use increases 8-fold to compensate. This …

Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin

DS Paul, TJ Grevengoed, F Pascual, JM Ellis… - … et Biophysica Acta (BBA …, 2014 - Elsevier
In mice with temporally-induced cardiac-specific deficiency of acyl-CoA synthetase-1 (Acsl1
H−/−), the heart is unable to oxidize long-chain fatty acids and relies primarily on glucose for …

Increasing fatty acid oxidation elicits a sex-dependent response in failing mouse hearts

J Ritterhoff, TS McMillen, O Villet, S Young… - Journal of molecular and …, 2021 - Elsevier
Background Reduced fatty acid oxidation (FAO) is a hallmark of metabolic remodeling in
heart failure. Enhancing mitochondrial long-chain fatty acid uptake by Acetyl-CoA …

Targeting ACSL1 promotes cardiomyocyte proliferation and cardiac regeneration

Y Li, M Yang, J Tan, C Shen, S Deng, X Fu, S Gao, H Li… - Life Sciences, 2022 - Elsevier
Background Neonatal hearts have considerable regenerative potential within 7 days post
birth (P7), but the rate of regeneration is extremely low after P7. Interestingly, lipid …

[HTML][HTML] A novel mouse model of lipotoxic cardiomyopathy

HC Chiu, A Kovacs, DA Ford, FF Hsu… - The Journal of …, 2001 - Am Soc Clin Investig
Inherited and acquired cardiomyopathies are associated with marked intracellular lipid
accumulation in the heart. To test the hypothesis that mismatch between myocardial fatty …